Suppr超能文献

BW 723C86在大鼠Vogel冲突试验中的抗焦虑样作用是由5-HT2B受体介导的。

Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.

作者信息

Kennett G A, Trail B, Bright F

机构信息

Neurobehavioural Research, SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK.

出版信息

Neuropharmacology. 1998 Dec;37(12):1603-10. doi: 10.1016/s0028-3908(98)00115-4.

Abstract

The 5-HT2B receptor agonist, BW 723C86 (10, 30(mg/kg i.p. 30 min pre-test), increased the number of punishments accepted in a rat Vogel drinking conflict paradigm over 3 min, as did the benzodiazepine anxiolytics, chlordiazepoxide (2.5-10 mg/kg p.o. 1 h pre-test) and alprazolam (0.2-5 mg/kg p.o. 1 h pre-test), but not the 5-HT2C/2B receptor agonist, m-chlorophenylpiperazine (mCPP, 0.3-3 mg/kg i.p) or the 5-HT1A receptor agonist, buspirone (5-20 mg/kg p.o. 1 h pre-test). The effect of BW 723C86 was unlikely to be secondary to enhanced thirst, as BW 723C86 did not increase the time that rats with free access to water spent drinking, nor did it reduce sensitivity to shock in the apparatus. The anti-punishment effect of BW 723C86 was opposed by prior treatment with the 5-HT2/2B receptor antagonist, SB-206553 (10 and 20 mg/kg p.o. 1 h pre-test), and the selective 5-HT2B receptor antagonist, SB-215505 (1 and 3 mg/kg p.o. 1 h pre-test), but not by the selective 5-HT2C receptor antagonist, SB-242084 (5 mg/kg p.o.), or the 5-HT1A receptor antagonist, WAY 100635 (0.1 or 0.3 mg/kg s.c. 30 min pre-test). Thus, the anti-punishment action of BW 723C86 is likely to be 5-HT2B receptor mediated. This is consistent with previous reports that BW 723C86 exhibited anxiolytic-like properties in both the social interaction and Geller-Seifter conflict tests.

摘要

5-羟色胺2B受体激动剂BW 723C86(10、30毫克/千克,腹腔注射,测试前30分钟),在大鼠Vogel饮水冲突范式中,能增加3分钟内接受惩罚的次数,苯二氮䓬类抗焦虑药氯氮卓(2.5 - 10毫克/千克,口服,测试前1小时)和阿普唑仑(0.2 - 5毫克/千克,口服,测试前1小时)也有同样效果,但5-羟色胺2C/2B受体激动剂间氯苯哌嗪(mCPP,0.3 - 3毫克/千克,腹腔注射)或5-羟色胺1A受体激动剂丁螺环酮(5 - 20毫克/千克,口服,测试前1小时)则没有此效果。BW 723C86的作用不太可能继发于口渴增强,因为BW 723C86既没有增加自由饮水大鼠的饮水时间,也没有降低仪器中对电击的敏感性。BW 723C86的抗惩罚作用被5-羟色胺2/2B受体拮抗剂SB - 206553(10和20毫克/千克,口服,测试前1小时)以及选择性5-羟色胺2B受体拮抗剂SB - 215505(1和3毫克/千克,口服,测试前1小时)预先处理所拮抗,但未被选择性5-羟色胺2C受体拮抗剂SB - 242084(5毫克/千克,口服)或5-羟色胺1A受体拮抗剂WAY 100635(0.1或0.3毫克/千克,皮下注射,测试前30分钟)所拮抗。因此,BW 723C86的抗惩罚作用可能是由5-羟色胺2B受体介导的。这与之前关于BW 723C86在社交互动和盖勒-赛弗特冲突测试中表现出抗焦虑样特性的报道一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验